Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysis

被引:0
|
作者
Meng-Die Chen
Si-Si Dong
Ning-Yu Cai
Meng-Di Fan
Su-Ping Gu
Jin-Jue Zheng
Hai-Min Yin
Xin-He Zhou
Liang-Xue Wang
Chun-Ying Li
Chao Zheng
机构
[1] The Second Affiliated Hospital of Wenzhou Medical University,Diabetes Center and Department of Endocrinology
[2] The Second Affiliated Hospital of Wenzhou Medical University,Department of Orthopedics
关键词
Mineralocorticoid receptor antagonists; Heart failure; Diabetes mellitus;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Efficacy and safety of bexagliflozin in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
    Pasqualotto, Eric
    Watanabe, Janine Midori Figueiredo
    Gewehr, Douglas Mesadri
    Maintinguer, Raphaela da Silva
    van de Sande-Lee, Simone
    de Araujo, Gustavo Neves
    Leal, Fidel Silveira
    Pinheiro, Carlos Eduardo Andrade
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (07): : 1794 - 1802
  • [22] Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis
    Jhund, Pardeep S.
    Talebi, Atefeh
    Henderson, Alasdair
    Claggett, Brian L.
    Vaduganathan, Muthiah
    Desai, Akshay S.
    Lam, Carolyn S. P.
    Pitt, Bertram
    Senni, Michele
    Shah, Sanjiv J.
    Voors, Adriaan A.
    Zannad, Faiez
    Solomon, Scott
    McMurray, John J., V
    [J]. LANCET, 2024, 404 (10458): : 1119 - 1131
  • [23] Efficacy and safety of luseogliflozin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Galigutta, Reddikumar Reddy
    Hasik, P. N.
    Thomas, Christy
    Undela, Krishna
    [J]. ENDOCRINE, 2024,
  • [24] Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Chronic Kidney Disease
    Khan, Mohammad Saud
    Khan, Muhammad Shahzeb
    Moustafa, Abdelmoniem
    Anderson, Allen S.
    Mehta, Rupal
    Khan, Sadiya S.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (04): : 643 - 650
  • [25] The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure
    Pitt, Bertram
    Rossignol, Patrick
    [J]. EXPERT OPINION ON DRUG SAFETY, 2016, 15 (05) : 659 - 665
  • [26] Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: a systematic review and network meta-analysis of 32 randomized trials
    Pamporis, Konstantinos
    Karakasis, Paschalis
    Sagris, Marios
    Zarifis, Ippokratis
    Bougioukas, Konstantinos I.
    Pagkalidou, Eirini
    Milaras, Nikias
    Samaras, Athanasios
    Theofilis, Panagiotis
    Fragakis, Nikolaos
    Tousoulis, Dimitris
    Xanthos, Theodoros
    Giannakoulas, George
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (07)
  • [27] SYSTEMATIC REVIEW AND META-ANALYSIS ON CARDIOVASCULAR OUTCOMES OF PATIENTS ON DIALYSIS RECEIVING MINERALOCORTICOID RECEPTOR ANTAGONISTS
    Chung, E.
    Lin, R.
    Negishi, K.
    Komala, M. G.
    [J]. NEPHROLOGY, 2021, 26 : 26 - 26
  • [28] A systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis
    Korol, Sandra
    Mottet, Fannie
    Perreault, Sylvie
    Baker, William L.
    White, Michel
    de Denus, Simon
    [J]. MEDICINE, 2017, 96 (48)
  • [29] Mineralocorticoid receptor antagonists as prevention in atrial fibrillation: a systematic review and meta-analysis
    Neefs, J.
    Van Den Berg, N. W. E.
    Limpens, J.
    Berger, W. R.
    De Groot, J. R.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 287 - 288
  • [30] Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis
    Davor Vukadinović
    Amr Abdin
    Insa Emrich
    P. Christian Schulze
    Stephan von Haehling
    Michael Böhm
    [J]. Clinical Research in Cardiology, 2023, 112 : 954 - 966